News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Landmark Clinical Research With the On-X Life Technologies, Inc. Heart Valve in a Poorly Anticoagulated South African Patient Group to be Presented at Major U.S. Heart Centers


9/1/2011 10:11:10 AM

AUSTIN, Texas, Sept. 1, 2011 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that Mervyn Williams, M.D., of Port Elizabeth, South Africa, will present the results of a Ten-year Clinical Study with the On-X® Prosthetic Heart Valve in Poorly Anticoagulated Patients in South Africa. The study of these marginally compliant patients has led to the view that the On-X valve may be able to adapt to fluctuations in anticoagulation with all types of patients.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES